This happens to most people
You're Not Alone
Common Reasons for GLP-1 Denials
Common reasons include a formulary exclusion (your plan doesn't cover the drug), a medical necessity denial, or a denial letter that doesn't clearly say why.
Getting denied doesn't mean the answer is no forever. It means the insurer needs more information — or you need to push back. The majority of people who appeal with proper documentation get approved. (Success rates vary by denial type and documentation quality.)
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get starteddenied approved
Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.
"I found Honest Care online and was very impressed with the letter... the appeal worked!"
"My Appeal was approved the next day. Thank you Honest Care!"
Find your denial reason below
Why Were You Denied?
Find the language from your denial letter below. Each denial type has a different appeal strategy:
| What Your Letter Says | What It Means | First Move |
|---|---|---|
| "Not medically necessary" or "doesn't meet clinical criteria" | Insurer claims you don't need Zepbound — but clinical evidence says otherwise | Strengthen your LOMN → |
| "Does not meet BMI criteria" or "weight requirements not met" | Documentation gap on your weight history or comorbidities | Document BMI + comorbidities → |
| "Not on formulary" or "non-preferred" or "excluded medication" | Plan business decision, not a medical one — you can request an exception | Request formulary exception → |
| "Lifestyle modification not documented" or "no proof of diet/exercise" | Missing records of weight management attempts | Add physician attestation → |
| "Step therapy required" or "must try other medications first" | Insurer wants you to try cheaper alternatives before Zepbound | Appeal with clinical evidence → |
Not sure which applies? Start with the appeal workflow — it covers all denial types.
What Insurers Look For in Approvals
- BMI documentation — Recent measurements (check your plan's specific requirements)
- Comorbidity codes — Type 2 diabetes, hypertension, sleep apnea, etc.
- Prior medication history — What you've tried before and why it failed
- Lifestyle modification proof — Diet/exercise programs, dietitian visits
- Physician letter of medical necessity — Explaining why Zepbound specifically
Missing any of these is a common reason for denial. Your appeal should address the gap.
Step-by-step process
How to Appeal a Zepbound Denial
Below is the process that leads to successful appeals. You can complete it yourself — or let Honest Care guide you through each step.
1Review Your Denial Letter
Review Your Denial Letter
Your denial letter contains important clues about why you were rejected and what evidence to gather.
- Find the specific reason code — look for a paragraph such as "Your request was denied because..."
- Check which denial category it matches in the triage table above
- Note the deadline — you have 180 days from denial date to appeal
2Gather Required Documentation
Gather Required Documentation
Different denial types require different documentation. Focus on what your specific denial needs.
- Medical necessity denial: Strong Letter of Medical Necessity (LOMN), clinical trial data
- BMI criteria denial: Recent weight measurements, comorbidity documentation
- Formulary exclusion: Exception request form, why Zepbound specifically
- Lifestyle documentation: Diet/exercise records, physician attestation
See the detailed sections below for specific templates and requirements.
3Write Your Appeal Letter
Write Your Appeal Letter
Your appeal letter should directly address the denial reason with specific evidence.
- Reference the denial: Include claim number, date, and exact denial reason
- Counter each point: Address each reason they cited with evidence
- Cite clinical data: SURMOUNT-1 (about 21% average weight loss at the highest dose), SUMMIT trial (38% lower risk of CV death or worsening heart failure in HFpEF with obesity)
- Include supporting docs: LOMN, lab results, prior med history
4Submit Your Appeal
Submit Your Appeal
- Submission methods: Insurer portal, fax, or certified mail (portal is fastest)
- Keep copies: Save everything you submit with date stamps
- Request confirmation: Get a reference number for your appeal
- Response time: For a prior authorization (pre-service) appeal, plans must decide within 30 days (60 days for services already received; 72 hours for urgent appeals)
5External Review (If Needed)
External Review (If Needed)
If your internal appeal is denied, you can request an independent external review. This decision is binding on your insurer.
- Deadline: 4 months from final internal denial (some states allow longer)
- Cost: Free or low-cost for you (some state processes charge a small fee); check your state's process
- Result: If the reviewer approves, your insurer must cover the medication
See External Review Guide for state-specific details.
Bottom line: 65%+ of appeals succeed with proper documentation. Most people never file an appeal.[4]
Start Your Appeal →"Not medically necessary" response
Medical Necessity Denials
When your insurer says Zepbound isn't "medically necessary," they're claiming either that obesity isn't a disease, your documentation is incomplete, or it's "cosmetic." All of these are rebuttable.
Letter of Medical Necessity (LOMN) Template
+
What Your LOMN Must Include
- Patient info (name, DOB, member ID, case/reference ID)
- Provider info (name, NPI, specialty, contact)
- The exact denial language being appealed
- Clinical rationale for why Zepbound is necessary
- Supporting evidence (trial data, guidelines)
OPENING:
"Dear Medical Director, I am writing to appeal the denial of coverage for Zepbound (tirzepatide) for [Patient Name]. The denial stated: '[exact denial language].' I respectfully request reconsideration based on the following clinical information demonstrating medical necessity."
CLINICAL SUMMARY:
Include: Current diagnosis with ICD-10 codes (E66.9 obesity, plus comorbidities), BMI history, prior treatment attempts and outcomes.
CLOSING:
"Based on the above clinical evidence, continued obesity without effective treatment poses significant health risks. Zepbound is medically necessary to reduce these risks. Sincerely, [Provider Name, NPI]"
Official resource: Download Lilly's LOMN template (PDF)
Clinical Evidence for Your Appeal
+
| Trial | Population | Result |
|---|---|---|
| SURMOUNT-1 | Obesity without T2D | About 21% average weight loss at 72 weeks (15 mg; 3% with placebo) |
| SURMOUNT-2 | Obesity + Type 2 diabetes | 14.7% average weight loss at 72 weeks (15 mg; 3.2% with placebo) |
| SUMMIT | Heart failure with preserved ejection fraction (HFpEF) and obesity | 38% reduction in CV death/worsening HF |
How to cite:
"In the SURMOUNT trials, tirzepatide produced about 15-21% average weight loss at 72 weeks at the highest dose, compared with about 3% in the placebo groups, which also received lifestyle counseling. In patients with HFpEF and obesity, the SUMMIT trial showed a 38% lower risk of cardiovascular death or worsening heart failure."
Counter-Arguments for Common Denial Reasons
+
"Weight loss is cosmetic"
"Obesity is recognized as a chronic disease by the AMA (2013), WHO, and CDC. It increases risk of cardiovascular disease, type 2 diabetes, and premature mortality. The FDA approved Zepbound specifically for treating obesity (BMI ≥30) or overweight (BMI ≥27) with comorbidities—not for cosmetic purposes."
"Lifestyle modification not documented"
"[Patient] has participated in supervised weight management for [X months], with [X%] weight loss that was not sustained. In the SURMOUNT trials, participants given lifestyle counseling with placebo lost about 3% of body weight, while those on the highest tirzepatide dose lost about 15-21%."
Attach: Provider notes documenting diet/exercise program participation.
"Step therapy not completed"
"[Patient] has tried [medications with dates, doses, outcomes]. [Drug] was discontinued due to [adverse effects/inefficacy]. Requiring additional step therapy delays treatment for a serious chronic disease."
"Does not meet BMI requirements" response
BMI Criteria Denials
Zepbound is FDA-approved for adults with obesity, or with overweight plus a weight-related condition (the label defines these as BMI ≥30, or BMI ≥27 with at least one weight-related condition). Some insurers set stricter thresholds.
BMI Requirements by Insurer
+
| Insurer | BMI Threshold | Comorbidity Requirement |
|---|---|---|
| Aetna | ≥30 or ≥27 | 1+ comorbidity if BMI 27-29.9 |
| UnitedHealthcare | ≥30 or ≥27 | 1+ comorbidity if BMI 27-29.9 |
| Cigna | ≥30 or ≥27 | 1+ comorbidity if BMI 27-29.9 (policy IP0816) |
| Blue Cross Blue Shield | ≥30 or ≥27 | Varies by state/plan |
| Anthem | Varies by plan | Some plans exclude weight loss drugs |
| Kaiser Permanente | Varies by region and plan | Check your Kaiser formulary |
Even within the same insurer, requirements vary by plan. Always verify your specific plan's criteria.
Qualifying Comorbidities + ICD-10 Codes
+
If your BMI is 27-29.9, documenting these conditions is essential:
| Condition | ICD-10 Code | Documentation Needed |
|---|---|---|
| Type 2 Diabetes | E11.x | A1C results, medication list |
| Hypertension | I10 | BP readings ≥130/80, medication list |
| Dyslipidemia | E78.5 | Lipid panel results |
| Sleep Apnea (OSA) | G47.33 | Sleep study with AHI score |
| Heart Disease | I25.x | Cardiology notes, imaging |
| PCOS | E28.2 | OB/GYN diagnosis, hormone tests |
BMI Appeal Tips
+
- Get current measurement: Plans want a recent, dated BMI (check your plan's time window)
- Include historical weight: Many policies (Aetna and Cigna, for example) use your baseline BMI from before you started a GLP-1
- Document all comorbidities: Even borderline conditions can help qualify you
- Request peer-to-peer: Your doctor can call the insurer's medical director directly
Sample appeal language:
"[Patient]'s current BMI is [X] kg/m², documented on [date]. Per FDA labeling, Zepbound is indicated for adults with obesity (BMI ≥30), or with overweight (BMI ≥27) and at least one weight-related comorbid condition. [Patient] has the following documented comorbidities: [list with ICD-10 codes]."
"Not on formulary" or "not covered" response
Formulary Exclusion Denials
When Zepbound is "not on formulary" or "not covered," it means it's not on your plan's approved drug list. This can be a business decision, not a medical one — and you can request an exception.
Types of "Not Covered" Denials
+
| Type | What It Means | Can You Get Coverage? |
|---|---|---|
| Formulary Exclusion | Zepbound isn't on your plan's drug list | Yes—request a formulary exception |
| Weight Loss Drug Exclusion | Plan excludes ALL weight loss meds | Harder—try OSA indication or employer advocacy |
| PA Denied | Drug IS on formulary but didn't meet criteria | Yes—appeal the denial |
Insurer/PBM Coverage Status (2026)
+
| Insurer/PBM | Status | Notes |
|---|---|---|
| CVS Caremark | Preferred again | Since October 1, 2026, Zepbound is back on CVS Caremark’s commercial template formularies as an additional preferred option (plan sponsors can customize). (From July 1, 2025 to September 30, 2026, Zepbound was nonpreferred or excluded on CVS Caremark’s most common commercial formularies, with Wegovy preferred.) Some employer plans may still exclude it; check your formulary. |
| Express Scripts | Varies | Depends on specific employer plan. |
| UnitedHealthcare | Varies | Depends on employer plan. PA required when covered. |
| Aetna | Varies | Standard criteria: at least 6 months in a weight-management program. |
| Blue Cross Blue Shield | Varies | Some plans exclude all weight loss drugs. |
| Medicare Part D | Limited | Medicare GLP-1 Bridge: $50 per monthly fill for the Zepbound KwikPen only (not vials or single-dose pens), July 1, 2026 – December 31, 2027, if you meet CMS's criteria and your prescriber gets prior authorization. |
How to Request a Formulary Exception
+
The key: Document why formulary alternatives (like Wegovy) don't work for you.
- If Wegovy didn't work: Get records showing inadequate weight loss
- If you had side effects: Document nausea, vomiting, etc.
- If medically contraindicated: Explain why you can't take the alternative
- If already on Zepbound: Switching could harm your progress
Exception request opening:
"I am writing to request a formulary exception for Zepbound (tirzepatide) for [Patient Name]. I understand Zepbound is not on [Plan]'s formulary. However, formulary alternatives are inappropriate because [Patient] previously tried [Wegovy] with [inadequate response/adverse effects]."
Alternative pathway: If your plan excludes weight loss drugs entirely, Zepbound is FDA-approved for obstructive sleep apnea — a different coverage pathway.
"No proof of diet/exercise" response
Lifestyle Documentation Denials
Many insurers require documented diet and exercise attempts before approving Zepbound (the required length varies by plan). Without proper documentation, you'll be denied — even if you've been trying to lose weight for years.
Requirements by Insurer
+
| Insurer | Duration | Key Requirements |
|---|---|---|
| UnitedHealthcare | No set length in UHC's policy | Used alongside lifestyle changes (diet, exercise, behavioral support); renewal needs continued lifestyle changes |
| Aetna | at least 6 months in a weight-management program | Comprehensive program with diet, activity and behavioral changes, before drug therapy |
| Blue Cross Blue Shield | Varies by plan | Medical record documentation preferred |
| Cigna | at least 3 months of behavioral modification and dietary restriction | Before starting; continued alongside treatment |
Physician Attestation Template
+
Ask your doctor to include language like this in your medical record:
"I, Dr. [Name], have supervised [Patient] in a structured lifestyle modification program from [start date] to [end date].
The program consisted of: • Nutritional counseling targeting 500-1,000 kcal/day reduction • Exercise guidance targeting 150+ minutes moderate activity/week • Regular follow-up visits for weight monitoring
Patient weight history: • Starting weight: ___ lbs (date) • Current weight: ___ lbs (date) • Net change: ___ lbs (___ %)
Despite documented compliance, [Patient] was unable to achieve clinically significant weight loss (≥5% body weight). Pharmacologic therapy with Zepbound is medically necessary."
What Documentation Counts
+
Strongest (most likely to be accepted):
- Physician chart notes documenting diet/exercise counseling with dates
- Weight records showing measurements over 3-6+ months
- Registered dietitian visit summaries
- Medical records from supervised weight loss programs
Supporting (strengthens your case):
- Gym membership records with usage logs
- Food diary/tracking app exports (MyFitnessPal)
- Activity tracker data (Fitbit, Apple Watch)
Supporting documentation alone may not be enough. You need medical records showing provider involvement.
3 immediate steps
What to Do Right Now
Find Your Denial Letter
Look for the specific reason they denied you. Look for a paragraph such as "Your request was denied because..." This determines your appeal strategy.
Note Your Deadline
You have 180 days from the denial date to file an internal appeal (under most plans). Missing this deadline typically forfeits your right to appeal. Mark it on your calendar.
Start Your Appeal
Honest Care writes your personalized appeal letter for free. We'll ask a few questions about your situation and denial, then create an insurer-ready letter.
Get Free Appeal Letter →Need Zepbound while your appeal is processing? Many patients use LillyDirect or other affordability options to start treatment while waiting for insurance approval.
Plan won't cover Zepbound at all? Other GLP-1s like Wegovy, Mounjaro, or the new oral option Foundayo may have different coverage on your plan. Compare Zepbound alternatives →
If your internal appeal is denied
External Review
Don't Give Up After Internal Denial
External reviews have higher success rates than internal appeals. An independent reviewer (not employed by your insurer) evaluates your case, and their decision is binding on your insurance company.
How External Review Works
- File within 4 months of your final internal denial (some states allow longer)
- Free or low-cost (some state processes charge a small fee) — check your state's process
- Independent reviewer evaluates your case objectively
- Binding decision — if approved, insurer must cover the medication
State Protections
| State | Key Protection | Notes |
|---|---|---|
| New York | State external appeal (you must request it) | Run by the Department of Financial Services for state-regulated plans |
| California | Independent Medical Review (IMR) | SB 1120 requires medical necessity denials to be decided by a licensed health professional, not an algorithm alone |
| Texas | State external review | Expedited review available for urgent cases |
| Florida | ACA minimums | Federal protections apply |
All states must comply with ACA external review requirements: right to independent review, 45-day decision timeline (72 hours if expedited).
The numbers are on your side
Appeals Actually Work
The appeal process exists for a reason—use it.
Step-by-step process, strategies, and documentation checklist
Impressive and successful!
My doctor did not even try to appeal when zepbound was originally denied, and the thought of appealing myself was overwhelming. I found Honest Care online and was very impressed with the letter and su...
I was denied coverage of my zepbound due to my company changed their requirements. After going over the appeal letter with my doctor (she was incredibly impressed) we submitted and got approved within...
Honest Care gets results!
My insurance refused prior authorization for Zepbound, but said I could file an appeal. I received my Appeal was approved the next day. Thank you Honest Care for helping me get my life back.
Common questions after a denial
Quick Answers
Yes. You have several options: (1) Appeal the denial — 65%+ of appeals succeed with proper documentation. (2) Pay cash — LillyDirect ($299–$449/month; TrumpRx.gov lists the same Lilly self-pay prices and orders go through LillyDirect), or Foundayo oral GLP-1 ($149–$299/month). (3) Try a different pathway — If you have sleep apnea, Zepbound may be covered under that indication even if weight loss is excluded.
You typically have 180 days from the date on your denial letter to file an internal appeal (check your plan documents for exact deadlines). After that, you may lose your right to appeal. Mark your calendar and don't wait.
Good. 65%+ of appeals succeed when you have proper documentation (AMA/KFF data). The key is addressing the specific reason you were denied and providing the right evidence.
Yes. LillyDirect offers the Zepbound KwikPen or vials at $299–$449/month (TrumpRx.gov lists the same Lilly self-pay prices; orders go through LillyDirect), and Foundayo (oral GLP-1) is $149–$299/month. This lets you start treatment while your appeal is pending. If your appeal succeeds, ask your plan whether it will reimburse any cash purchases; many plans won't.
A Letter of Medical Necessity is a document from your doctor explaining why Zepbound is medically necessary for your specific situation. It should include your diagnosis, BMI, weight history, comorbidities, failed treatments, and clinical evidence supporting tirzepatide. A strong LOMN is the most important document for winning an appeal.
Most insurers require a BMI of 30 or higher (obesity), OR a BMI of 27+ with at least one weight-related comorbidity like type 2 diabetes, hypertension, high cholesterol, or sleep apnea. Some plans set higher thresholds (for example, BMI 35+). Check your specific plan's criteria.
You can request a formulary exception — a formal request for your insurer to cover a non-formulary drug. Your doctor provides clinical justification for why you specifically need Zepbound vs. alternatives. If denied, you can appeal the exception denial using the standard appeal process.
Insurers typically want evidence of diet and exercise attempts before approving Zepbound. The required length varies: Cigna asks for at least 3 months of behavioral modification and dietary restriction; Aetna's standard criteria, at least 6 months in a weight-management program. This can include: food/exercise logs, weight tracking records, dietitian visits, gym memberships, or a physician attestation letter confirming supervised lifestyle modification efforts.
Yes. If your internal appeal is denied, you can request an external review by an independent third party. External review decisions are binding on your insurer — if you win, they must cover Zepbound. You typically have 4 months to request external review after an internal appeal denial.
Some insurers use automated systems in initial reviews. On appeal, federal rules for employer and ACA plans require a fresh review: your appeal must be decided by someone other than the person who denied it, in consultation with a qualified health care professional when medical judgment is involved. Use the appeal to put your full medical history in front of that reviewer.
WHAT'S CHANGING
Zepbound Denials: 2026 Outlook
2026: Mixed Outlook for Coverage
While some employers cover GLP-1s for weight loss (43% of firms with 5,000+ workers, and 16% of firms with 200–999 workers (2025)), plans can still deny coverage through PA requirements and cost-management rules. Since July 1, 2026, the Medicare GLP-1 Bridge has covered the Zepbound KwikPen for qualifying beneficiaries at $50 per monthly fill (through December 31, 2027).
CMS Prior Authorization Reform
The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) took effect January 1, 2026 for some plans:
- Faster decisions: 72 hours urgent, 7 calendar days standard, for Medicare Advantage, Medicaid and CHIP
- Transparency: Plans must give a specific reason for prior authorization denials
- Not for drugs: The rule excludes drugs and doesn't cover employer plans, so it doesn't change Zepbound pharmacy prior authorization timelines
- Digital integration: PA requests through electronic health records
If Appeals Fail: Cash Pay Option
For patients who exhaust appeal options:
- LillyDirect — Zepbound KwikPen or vials at $299–$449/month (reduced cash pricing)
- TrumpRx.gov — TrumpRx lists the manufacturers’ own self-pay prices (not a separate, cheaper price); Zepbound orders go through LillyDirect (launched February 5, 2026)
- Foundayo — Lilly's new oral GLP-1 at $149–$299/month self-pay (learn more)
Denied Another GLP-1?
Appeal strategies are similar across GLP-1 medications:
References
- HealthCare.gov. "Internal appeals" (file within 180 days of the denial notice). healthcare.gov
- KFF. 2025 Employer Health Benefits Survey: 43% of firms with 5,000+ workers, and 16% of firms with 200–999 workers (2025) covered GLP-1s for weight loss. kff.org
- American Medical Association / Kaiser Family Foundation. Prior authorization appeal success data. Note: AMA reports 80%+ for Medicare Advantage; we use a conservative 65%+ estimate for commercial insurance plans. ama-assn.org
- Kaiser Family Foundation. "Claims Denials and Appeals in ACA Marketplace Plans." KFF Analysis, 2023. kff.org
Disclaimer
The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.
While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.